BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22218442)

  • 21. Challenges in surgical pathology of adrenocortical tumours.
    Erickson LA
    Histopathology; 2018 Jan; 72(1):82-96. PubMed ID: 29239032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiling of childhood adrenocortical tumors.
    West AN; Neale GA; Pounds S; Figueredo BC; Rodriguez Galindo C; Pianovski MA; Oliveira Filho AG; Malkin D; Lalli E; Ribeiro R; Zambetti GP
    Cancer Res; 2007 Jan; 67(2):600-8. PubMed ID: 17234769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and molecular aspects of a pediatric metachronous adrenocortical tumor.
    Lima Lde O; Lerario AM; Alencar GA; Brito LP; Almeida MQ; Domenice S; Latronico AC; Mendonca BB; Fragoso MC
    Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):72-7. PubMed ID: 21468523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.
    Leal LF; Mermejo LM; Ramalho LZ; Martinelli CE; Yunes JA; Seidinger AL; Mastellaro MJ; Cardinalli IA; Brandalise SR; Moreira AC; Tone LG; Scrideli CA; Castro M; Antonini SR
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3106-14. PubMed ID: 21849527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sum of High-Risk Gene Mutation (SHGM): A Novel Attempt to Assist Differential Diagnosis for Adrenocortical Carcinoma with Benign Adenoma, Based on Detection of Mutations of Nine Target Genes.
    Zheng GY; Zhang XB; Li HZ; Zhang YS; Deng JH; Wu XC
    Biochem Genet; 2021 Aug; 59(4):902-918. PubMed ID: 33564960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virilising adrenocortical tumours in children.
    Bonfig W; Bittmann I; Bechtold S; Kammer B; Noelle V; Arleth S; Raile K; Schwarz HP
    Eur J Pediatr; 2003 Sep; 162(9):623-8. PubMed ID: 12811553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation.
    Ronchi CL; Di Dalmazi G; Faillot S; Sbiera S; Assié G; Weigand I; Calebiro D; Schwarzmayr T; Appenzeller S; Rubin B; Waldmann J; Scaroni C; Bartsch DK; Mantero F; Mannelli M; Kastelan D; Chiodini I; Bertherat J; Reincke M; Strom TM; Fassnacht M; Beuschlein F;
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3526-38. PubMed ID: 27389594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric adrenocortical tumors: morphological diagnostic criteria and immunohistochemical expression of matrix metalloproteinase type 2 and human leucocyte-associated antigen (HLA) class II antigens. Results from the Italian Pediatric Rare Tumor (TREP) Study project.
    Magro G; Esposito G; Cecchetto G; Dall'Igna P; Marcato R; Gambini C; Boldrini R; Collini P; D'Onofrio V; Salfi N; d'Amore E; Ferrari A; Bisogno G; Alaggio R
    Hum Pathol; 2012 Jan; 43(1):31-9. PubMed ID: 21820153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
    Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
    Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
    Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
    Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.
    Romero Arenas MA; Whitsett TG; Aronova A; Henderson SA; LoBello J; Habra MA; Grubbs EG; Lee JE; Sircar K; Zarnegar R; Scognamiglio T; Fahey TJ; Perrier ND; Demeure MJ
    Ann Surg Oncol; 2018 Mar; 25(3):801-807. PubMed ID: 29218429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of disease: adrenocortical tumors--molecular advances and clinical perspectives.
    Bertherat J; Groussin L; Bertagna X
    Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):632-41. PubMed ID: 17082810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long Noncoding RNA Expression in Adrenal Cortical Neoplasms.
    Shiyanbola O; Hardin H; Hu R; Eickhoff JC; Lloyd RV
    Endocr Pathol; 2020 Dec; 31(4):385-391. PubMed ID: 32725507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular pathways of human adrenocortical carcinoma - translating cell signalling knowledge into diagnostic and treatment options.
    Szyszka P; Grossman AB; Diaz-Cano S; Sworczak K; Dworakowska D
    Endokrynol Pol; 2016; 67(4):427-50. PubMed ID: 27387247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression profiles of the glucose-dependent insulinotropic peptide receptor and LHCGR in sporadic adrenocortical tumors.
    Costa MH; Latronico AC; Martin RM; Barbosa AS; Almeida MQ; Lotfi CF; Valassi HP; Nishi MY; Lucon AM; Siqueira SA; Zerbini MC; Carvalho LR; Mendonca BB; Fragoso MC
    J Endocrinol; 2009 Feb; 200(2):167-75. PubMed ID: 18971217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sonic hedgehog signaling is active in human adrenal cortex development and deregulated in adrenocortical tumors.
    Gomes DC; Leal LF; Mermejo LM; Scrideli CA; Martinelli CE; Fragoso MC; Latronico AC; Tone LG; Tucci S; Yunes JA; Cardinalli IA; Mastellaro MJ; Brandalise SR; Ramalho F; Moreira AC; Ramalho LN; de Castro M; Antonini SR
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1209-16. PubMed ID: 24712566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular genetic markers and criteria for the prediction of adrenocortical carcinoma].
    Selivanova LS; Roslyakova AA; Bogolyubova AV; Tertychnyi AS; Beltsevich DG; Abrosimov AY; Melnichenko GA
    Arkh Patol; 2019; 81(5):92-96. PubMed ID: 31626211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis of adrenocortical carcinomas.
    Soon PS; Sidhu SB
    Minerva Endocrinol; 2009 Jun; 34(2):137-47. PubMed ID: 19471238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin.
    Heaton JH; Wood MA; Kim AC; Lima LO; Barlaskar FM; Almeida MQ; Fragoso MC; Kuick R; Lerario AM; Simon DP; Soares IC; Starnes E; Thomas DG; Latronico AC; Giordano TJ; Hammer GD
    Am J Pathol; 2012 Sep; 181(3):1017-33. PubMed ID: 22800756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.
    Brown TC; Nicolson NG; Korah R; Carling T
    J Am Coll Surg; 2018 Jun; 226(6):988-995. PubMed ID: 29428231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.